Physician profile
Christopher M Johnson
NPI 1295931350
$2,363.49
in general payments reported to CMS, 2019-2025
17 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $46.47 · 2021: $321 · 2022: $281 · 2023: $520 · 2024: $543 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Steris Corporation | $629.92 | 2023-2025 | |
| Stryker Corporation | $408.72 | 2019-2023 | Vsp System, Vsp Cranial, Duramatrix, Hydroset |
| Regeneron Healthcare Solutions, INC. | $327.94 | 2019-2025 | Dupixent, Libtayo |
| Axogen | $170.60 | 2025 | |
| Acera Surgical, INC. | $129.56 | 2023 | Restrata Wound Matrix |
| Inspire Medical Systems, INC. | $122.89 | 2022 | |
| Pentax of America, INC. | $122.04 | 2022 | |
| Integra Lifesciences Corporation | $121.44 | 2023 | Codman Isocool Aht, Integra Duo, Instruments-Orthopedic |
| Glaxosmithkline, LLC. | $96.40 | 2023 | Arexvy, Nucala |
| Olympus America INC. | $71.58 | 2019 | |
| Polynovo North America LLC | $57.51 | 2025 | Novosorb Btm |
| Fisher & Paykel Healthcare INC | $22.76 | 2023 | Fisher & Paykel Healthcare |
| Optinose US, INC. | $19.03 | 2022 | |
| Ethicon US, LLC | $18.97 | 2023 | Echelon Flex |
| Vertex Pharmaceuticals Incorporated | $17.86 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.64 | 2023 | |
| Csl Behring | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.